sponsored byAAAS Golden Fund




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 1001-1025 out of 1311.

<< < 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 > >>

Public Release: 17-Apr-2015
Antimicrobial Agents and Chemotherapy
New genetic mutation could signal start of malaria drug resistance in Africa
Early indicators of the malaria parasite in Africa developing resistance to the most effective drug available have been confirmed, according to new research from the London School of Hygiene & Tropical Medicine.

Contact: Katie Steels
London School of Hygiene & Tropical Medicine

Public Release: 16-Apr-2015
Subsidies key in improving sanitation, new study finds
For years, governments and major development institutions have vigorously debated how to address poor sanitation in developing countries, which causes 280,000 deaths per year worldwide. A new study released in Science today found that in Bangladesh, a community-motivation model that has been used in over 60 countries to increase use of hygienic latrines had no effect, but that latrine coverage expands substantially when that model is combined with subsidies for hygienic latrines targeted to the poor.

Contact: Heidi McAnnally-Linz
Innovations for Poverty Action

Public Release: 16-Apr-2015
PLOS Neglected Tropical Diseases
160 people die of rabies every day, says major new study
A global study on canine rabies, published April 16, 2015, has found that 160 people die every single day from the disease. The report is the first study to consider the impact in terms of deaths and the economic costs of rabies across all countries. Even though the disease is preventable, 59,000 people die every year of rabies transmitted by dogs, and the disease costs global economies $8.6 billion US.
UBS Optimus Foundation, Wellcome Trust

Contact: Kevin Doran
Global Alliance for Rabies Control

Public Release: 15-Apr-2015
Canada, India fund 5 innovations to improve health in India, with focus on mothers and children
Canada and India today announced investments of CDN $2.5 million in five innovations in India aimed primarily at improving maternal, newborn and child health -- Canada's flagship development priority. Canadian government-funded Grand Challenges Canada and the Grand Challenges India initiative of the Government of India, made the joint announcement during the official visit to Canada of India's Prime Minister Narendra Modi.
Grand Challenges Canada, Grand Challenges India

Contact: Lode Roels
Grand Challenges Canada

Public Release: 15-Apr-2015
DNA and Cell Biology
Fighting tuberculosis using the body's natural anti-microbial processes
A new approach to combatting tuberculosis would take advantage of a complex, natural process called autophagy that the human body uses to recycle nutrients, remove damaged cell components, eliminate invading bacteria, and respond to inflammation. In addition to its potential as a novel therapeutic strategy, autophagy is the focus of increasing research to understand the role it may have in a range of diseases including heart disease, diabetes, and age-related neurodegenerative disorders such as Alzheimer's disease.

Contact: Kathryn Ryan
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 14-Apr-2015
The Journal of Alternative and Complementary Medicine
Antimalarial tea -- from herbal remedy to licensed phytomedicine
Malaria is a critical health problem in West Africa, where traditional medicine is commonly used alongside modern healthcare practices. An herbal remedy derived from the roots of a weed, which was traditionally used to alleviate malarial symptoms, was combined with leaves and aerial portions from two other plants with antimalarial activity, formulated as a tea, and eventually licensed and sold as an antimalarial phytomedicine.

Contact: Kathryn Ryan
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 14-Apr-2015
Journal of Psychiatric Research
Wristband that measures rest, activity schedule may help predict response to antidepressants
A wristband that records motion throughout a 24-hour cycle may be an inexpensive, safe way to determine which patients with major depressive disorder will respond best to commonly prescribed drugs such as Prozac.

Contact: Toni Baker
Medical College of Georgia at Augusta University

Public Release: 14-Apr-2015
PLOS Medicine
How best to test Ebola treatment
An unconventional clinical trial design might have advantages over classical trials for testing treatments for Ebola virus disease (EVD), suggests a study published this week in PLOS Medicine. The work of an international team led by John Whitehead of Lancaster University, UK and Ben Cooper of Oxford University, UK, provides much-needed data to inform a debate on the scientific and ethical justification for non-randomized EVD trials.
Wellcome Trust, European Union, Medical Research Council, Department for International Development

Contact: Hugh O' Brien

Public Release: 13-Apr-2015
Health Affairs
The cost and quality of cancer care in Health Affairs' April issue
The April issue of Health Affairs contains a cluster of papers focusing on the cost and quality of cancer care. Other subjects covered in the issue: health care payment reform and the diminished number of uninsured young adults. Publication of the cancer studies in the April issue was supported by Precision Health Economics and the Celgene Corporation.

Contact: Sue Ducat
Health Affairs

Public Release: 13-Apr-2015
NIH, South African Medical Research Council award $8 million in HIV, TB grants
NIH and the South African Medical Research Council are awarding 31 grants to US and South African scientists to support research targeting HIV/AIDS, tuberculosis and HIV-related co-morbidities and cancers. The awards, which total $8 million in first-year funding, are the first to be issued through the South Africa-US Program for Collaborative Biomedical Research.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Kathy Stover
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 9-Apr-2015
Cell Reports
New Ebola study points to potential drug target
Opening the door to potential treatments for the deadly Ebola virus, scientists led by Washington University School of Medicine in St. Louis have shown that interfering with its replication can stop the virus in its tracks.
US Department of Defense, National Institutes of Health

Contact: Diane Duke Williams
Washington University School of Medicine

Public Release: 8-Apr-2015
UTMB researchers develop Ebola vaccine effective in a single dose
An interdisciplinary team from The University of Texas Medical Branch at Galveston and Profectus BioSciences, Inc. has developed a quick-acting vaccine that is both safe and effective with a single dose against the Ebola strain that killed thousands of people in West Africa last year. These findings are detailed in the new edition of Nature.
National Institutes of Health, UTMB Department of Microbiology and Immunology

Contact: Donna Ramirez
University of Texas Medical Branch at Galveston

Public Release: 8-Apr-2015
Science Translational Medicine
Plotting the elimination of dengue
Researchers at the University of Melbourne along with international collaborators are using a novel way to block the dengue virus in Aedes aegypti mosquitoes using the insect bacterium, Wolbachia and have for the first time provided projections of its public health benefit.

Contact: Anne Rahilly
University of Melbourne

Public Release: 8-Apr-2015
International Journal of Public Health
Case study Cabo Verde: Simulation offers policy Rx for curbing HIV
The African archipelago nation of Cabo Verde could bring its HIV epidemic under control within 10 years by ramping up a combination of four interventions already underway, according to projections from a sophisticated computer model led by Brown University public health researchers. Much of the progress could be achieved, the model predicts, by focusing the effort just on the most at-risk populations.
National Institutes of Health

Contact: David Orenstein
Brown University

Public Release: 8-Apr-2015
In first human study, new antibody therapy shows promise in suppressing HIV infection
In the first results to emerge from HIV patient trials of a new generation of so-called broadly neutralizing antibodies, Rockefeller University researchers have found the experimental therapy can dramatically reduce the amount of virus present in a patient's blood.
Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery, NIH/Cooperative Centers on Human Immunology, National Center for Advancing Translational Science, Robertson Foundation, NIH/National Cancer Institute

Contact: Zach Veilleux
Rockefeller University

Public Release: 7-Apr-2015
Journal of Allergy and Clinical Immunology
Asthma rates among black youth are similarly high in urban, rural communities
Asthma rates among black youth living in urban Detroit and rural Georgia are essentially the same, researchers report, a finding that conflicts with the widely held theory that city life is a risk factor, and pointing instead toward poverty.

Contact: Toni Baker
Medical College of Georgia at Augusta University

Public Release: 7-Apr-2015
Journal of Clinical Investigation
Gene variant and environment can boost severity of respiratory syncytial virus
A particular genetic mutation combined with an urban environment increases the risk of severe disease in children infected with respiratory syncytial virus, an international team of investigators has found.
Bill & Melinda Gates Foundation, National Institutes of Health

Contact: Craig Boerner
Vanderbilt University Medical Center

Public Release: 7-Apr-2015
PLOS Medicine
Epidemiology of HIV-1 transmitted drug resistance
Only a limited number of surveillance drug-resistance mutations are responsible for most instances of non-nucleoside reverse transcriptase inhibitor- and nucleoside reverse transcriptase inhibitor-associated resistance, and most strains of HIV-1 transmitted drug resistance in sub-Saharan Africa and south/southeast Asia arose independently, according to a study led by Soo-Yon Rhee of Stanford University, published this week in PLOS Medicine.
National Institutes of Health, Bill & Melinda Gates Foundation, Centers for AIDS Research

Contact: Maya Sandler

Public Release: 7-Apr-2015
PLOS Medicine
Stanford-led study finds limited mutations involved in transmission of drug-resistant HIV
In the largest study of its kind to date, researchers at Stanford University School of Medicine and their colleagues have found that worldwide only a limited number of mutations are responsible for most cases of transmission of drug-resistant HIV.
National Institutes of Health, Bill & Melinda Gates Foundation, Center for AIDS Research

Contact: Ruthann Richter
Stanford University Medical Center

Public Release: 6-Apr-2015
Obstetrician-gynecologist training in Sub-Saharan Africa bolstered by new collections
A new project provides free access to educational materials to support obstetrician-gynecologist training in Africa and improve maternal and newborn care.
World Bank

Contact: Beata Mostafavi
University of Michigan Health System

Public Release: 6-Apr-2015
Journal of Medical Entomology
For ticks, researchers find lemur noses to be males only in Madagascar
Out of 295 ticks collected from the noses of lemurs in Madagascar, 100 percent of them were male. The chosen location may provide a convenient jump-off point for male ticks to switch hosts as the lemurs sniff each other.

Contact: Richard Levine
Entomological Society of America

Public Release: 3-Apr-2015
Case Western Reserve to lead international research on resistance to bacteria causing TB
After discovering a unique group of people resistant to tuberculosis (TB) infection, Case Western Reserve researchers are leading an international team dedicated to understanding exactly how they fight off a disease that claims 1.5 million lives each year. The team's goal is to use lessons learned from these resistant individuals to develop an approach to treating and curing TB that is unlike any existing medication.
National Institutes of Health, Bill & Melinda Gates Foundation

Contact: Jeannette Spalding
Case Western Reserve University

Public Release: 3-Apr-2015
Annals of Emergency Medicine
Doctor at Rhode Island Hospital develops Ebola virus diagnostic tool
Adam C. Levine, M.D., an emergency medicine physician at Rhode Island Hospital and The Miriam Hospital who treated Ebola-infected patients in Liberia last year, used his field experience to create a tool to determine the likelihood that patients presenting with Ebola symptoms will actually carry the virus. His research was published in the Annals of Emergency Medicine today.

Contact: Beth Bailey

Public Release: 2-Apr-2015
New England Journal of Medicine
Deaths from cardiovascular disease increase globally while mortality rates decrease
Deaths from cardiovascular disease increase globally while mortality rates decrease.

Contact: Rhonda Stewart
Institute for Health Metrics and Evaluation

Public Release: 1-Apr-2015
PLOS Neglected Tropical Diseases
New class of insecticides offers safer, more targeted mosquito control
Purdue researchers have identified a new class of chemical insecticides that could provide a safer, more selective means of controlling mosquitoes that transmit key infectious diseases such as dengue, yellow fever and elephantiasis.
US Department of Defense, Purdue Research Foundation, Indiana Clinical and Translational Sciences Institute, NIH/National Center for Advancing Translational Science

Contact: Natalie van Hoose
Purdue University

Showing releases 1001-1025 out of 1311.

<< < 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 > >>